Call 888-776-0942 from 8 a.m. to 10 p.m. Eastern Time
The market size of electrophysiological catheters is driven by the high incidence of cardiovascular diseases and technological progress. The electrophysiological diagnostic catheter segment has the largest market share in the world, with the largest market share in 2021, at 60.36%. The diagnostics sector occupies a dominant position in the global market, with the largest market share in 2021, at 50.24%.
New York, December 9, 2021/PRNewswire/-According to the new market research report "Electrophysiology catheter market forecast to 2028-COVID-19 impact and global analysis-by product type (electrophysiology diagnostic catheter and electrophysiology) Ablation catheters)”; applications (diagnosis and monitoring, arrhythmia treatment, imaging and mapping); end users (hospitals, outpatient surgery centers, and cardiac catheterization laboratories)”, released by The Insight Partners, the market size of electrophysiological catheters is expected to reach The US dollar will increase from US$4.13318 billion in 2021 to US$7.2885 billion by 2028; it is expected to grow at a compound annual growth rate of 8.4% from 2021 to 2028.
Get an exclusive sample page of the electrophysiological catheter market size at https://www.theinsightpartners.com/sample/TIPRE00011640/-COVID-19 impact and strategic insight global analysis
Number of charts
North America; Europe; Asia Pacific; Latin America; Multilateral Environmental Agreements
United States, United Kingdom, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina
Revenue forecasts, company rankings, competitive landscape, growth factors and trends
Electrophysiological catheter market: competitive landscape and key developments
Companies such as MicroPort Scientific Corporation and Boston Scientific Corporation have implemented various inorganic developments that have purchased dynamic improvements in the electrophysiological catheter market they operate. Many companies are focusing on organic strategies, such as product launches and expansion. The inorganic growth strategy witnessed in the market is partnership and collaboration. These growth strategies have helped market participants expand their businesses and strengthen their geographic influence. In addition, growth strategies such as acquisitions and partnerships help strengthen their customer base and increase their product portfolio.
In August 2021, Wicresoft and Stereotaxis reached a cooperation to promote the technological innovation and commercial application of robotics in the field of electrophysiology in China. The agreement acquires MicroPort EP's commercial and product leadership in the Chinese electrophysiology market through Stereotaxis' advanced robotic magnetic navigation technology. As part of the cooperation, MicroPort EP became the exclusive distributor of electrophysiology robot magnetic navigation technology in China.
Download the sample PDF brochure of the electrophysiological catheter market size and growth research report at https://www.theinsightpartners.com/sample/TIPRE00011640/
In December 2020, BIOTRONIK's AlCath Force was approved by the CE market, enabling European electrophysiologists to use the most advanced gold tip force induction ablation catheter and provide a complete solution for complex treatments. A case of atrial fibrillation (AF).
In 2020, North America dominates the electrophysiological catheter market. The market growth in this region is attributed to the increasing prevalence of arrhythmia cases in the population. The increase in the number of cardiac ablation centers and the surgeries performed on a large number of patients are contributing to market growth. Due to the increasing investment of regional market leaders driving the growth of electrophysiological catheters, the electrophysiological catheter market in the Asia-Pacific region is expected to grow at the fastest rate during the forecast period.
Electrophysiological Catheter Market: Key Insights-Impact of COVID-19
The COVID-19 pandemic has severely affected hospital services. The hospital is crowded with COVID-19 and other routine patients. The surge in the number of COVID-19 patients has had a negative impact on the electrophysiological catheter market due to the reduction in the number of visits to avoid infection. However, as the government has formulated various guidelines to provide continuous and effective healthcare, major players in the electrophysiological catheter market are able to carry out various strategic initiatives, such as product launches, mergers and acquisitions, and partnerships to increase production capacity and meet demand . For example, in May 2021, a number of Wicresoft's self-developed products obtained registration approval from the Ministry of Health of Kazakhstan ("MOH"), marking the company's first entry into the Kazakhstan market. A total of 17 devices and catheters have been approved for use, including the FireMagic cardiac radiofrequency ablation catheter series for the diagnosis and treatment of arrhythmia, the EasyFinder diagnostic catheter series and the EasyLoop circular mapping catheter series. In addition, in Asia-Pacific countries, COVID-19 has caused an extraordinary emergency and disrupted the supply chain. Supply chain disruptions and the surge in demand for effective therapies to treat COVID-19 have put the healthcare research industry in a critical state. Nevertheless, the demand for electrophysiological procedures is high, which has led to continuous advancements in technology.
Purchase an advanced copy of the 2021-2028 electrophysiological catheter market size, share, revenue, strategic insights and forecast research report at https://www.theinsightpartners.com/buy/TIPRE00011640/
Electrophysiological Catheter Market: Overview of Market Segments
According to end users, the electrophysiological catheter market is divided into hospitals, outpatient surgery centers, and cardiac catheterization laboratories. By 2021, the hospital sector will account for the largest share of 60.55% and is expected to maintain its dominant position during the forecast period. In addition, it is expected that the same market segment will have the highest compound annual growth rate during the forecast period, at 8.7%. A report by the American Heart Association pointed out that the frequency of abnormal rhythms in middle-aged and elderly community residents is very high. Atrial fibrillation, bradyarrhythmias and conduction system diseases account for the majority of abnormal rhythm conditions. According to records, at least 2.3 million people in the United States alone are affected by arrhythmia, leading to an increased risk of stroke and death. In addition, 90,000 cases of supraventricular tachycardia are detected in the United States each year, accounting for 25% of all emergency department visits hospitalized for supraventricular tachycardia. In addition, the NCBI report pointed out that among the 5,585 people admitted to hospital due to arrhythmia, 2,020 (36.1%) also suffered from arrhythmia, which will benefit the market segment growth during the forecast period.
Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients obtain solutions that meet their research needs through our joint and consulting research services. We focus on industries such as semiconductors and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical equipment, technology, media and telecommunications, chemicals and materials.
If you have any questions about this report or want more information, please contact us:
Contact: Sameer Joshi Email: [Email protected] Phone: +1-646-491-9876 Press release: https://www.theinsightpartners.com/pr/electrophysiology-catheter-market More research: https: // www.openpr.com/news/archive/139407/The-Insight-Partners.html
More news releases on similar topics
Cision Distribution 888-776-0942 8 a.m. to 9 p.m. Eastern Time